TY  - JOUR
PY  - 2021//
TI  - Psychiatric hospitalization and length of stay differences in cannabis users and non-users with a primary discharge diagnosis of schizophrenia or schizoaffective disorder
JO  - Substance use and misuse
A1  - Williams, Steven R.
A1  - Agapoff, James R. 4th
A1  - Jalan, Devesh
A1  - Hishinuma, Earl S.
A1  - Kida, Lauren E.
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - BACKGROUND: The effects of cannabis use in vulnerable persons with schizophrenia or schizoaffective disorder, continues to be elucidated. <br><br>METHODS: We compared 55 cannabis-only users (Group 1) with 462 non-substance users (Group 2) on measures of length of stay and number of psychiatric hospitalizations with a primary discharge diagnosis of schizophrenia or schizoaffective disorder using the Wilcoxon-Mann-Whitney non-parametric test for non-normal distributions, analysis of variance (ANOVA), and Poisson regression analysis. <br><br>RESULTS: Group 1 had a mean length of stay of 6.15 days (sd = 5.32 days) and Group 2 had a mean length of stay of 8.66 days (sd = 11.14 days) (i.e. Wilcoxon-Mann-Whitney, p =.0347; log-transformed ANOVA, p =.0203). This difference was no longer statistically significant when controlling for three covariates (p =.1543). Poisson regressions for the mean number of admissions (1.84) were not statistically significant. <br><br>CONCLUSIONS: Cannabis use may not be a good predictor of length of stay, once covariates are considered, and mean number of hospitalizations in hospitalized patients with schizophrenia or schizoaffective disorder.<p />  <p>Language: en</p>
LA  - en
SN  - 1082-6084
UR  - http://dx.doi.org/10.1080/10826084.2021.1949615
ID  - ref1
ER  -